hexamethonium has been researched along with Disease Exacerbation in 1 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Two signatures of heart failure are activation of the sympathetic nervous system and catecholamine desensitization." | 1.30 | Effects of cardiac denervation on development of heart failure and catecholamine desensitization. ( Asai, K; Ghaleh-Marzban, B; Kudej, RK; Mirsky, I; Patrick, TA; Sato, N; Shannon, RP; Shen, YT; Uechi, M; Vatner, DE; Vatner, SF, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sato, N | 1 |
| Vatner, SF | 1 |
| Shen, YT | 1 |
| Kudej, RK | 1 |
| Ghaleh-Marzban, B | 1 |
| Uechi, M | 1 |
| Asai, K | 1 |
| Mirsky, I | 1 |
| Patrick, TA | 1 |
| Shannon, RP | 1 |
| Vatner, DE | 1 |
1 other study available for hexamethonium and Disease Exacerbation
| Article | Year |
|---|---|
Effects of cardiac denervation on development of heart failure and catecholamine desensitization.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Animals; Atropine Derivatives; Blood Pressure; | 1997 |